These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34806121)

  • 41. Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective study.
    van Gorkom T; Kremer K; Voet W; Notermans DW; Vlaminckx BJM; Sankatsing SUC; Thijsen SFT
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2137-2146. PubMed ID: 28748396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.
    Marangoni A; Moroni A; Accardo S; Cevenini R
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):349-54. PubMed ID: 18197445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
    Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.
    van Gorkom T; Sankatsing SUC; Voet W; Ismail DM; Muilwijk RH; Salomons M; Vlaminckx BJM; Bossink AWJ; Notermans DW; Bouwman JJM; Kremer K; Thijsen SFT
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
    Ledue TB; Collins MF; Young J; Schriefer ME
    Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.
    Wormser GP; Schriefer M; Aguero-Rosenfeld ME; Levin A; Steere AC; Nadelman RB; Nowakowski J; Marques A; Johnson BJ; Dumler JS
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):9-15. PubMed ID: 23062467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a sequential enzyme immunoassay testing algorithm for Lyme disease demonstrates lack of test independence but high diagnostic specificity.
    Wormser GP; Molins CR; Levin A; Lipsett SC; Nigrovic LE; Schriefer ME; Branda JA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):217-219. PubMed ID: 29550060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serodiagnosis of borreliosis: indirect immunofluorescence assay, enzyme-linked immunosorbent assay and immunoblotting.
    Wojciechowska-Koszko I; Mączyńska I; Szych Z; Giedrys-Kalemba S
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):69-77. PubMed ID: 21258869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease.
    Haddad NS; Nozick S; Ohanian S; Smith R; Elias S; Auwaerter PG; Lee FE; Daiss JL
    PLoS One; 2023; 18(11):e0293203. PubMed ID: 37922270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease.
    Rauer S; Kayser M; Neubert U; Rasiah C; Vogt A
    J Clin Microbiol; 1995 Oct; 33(10):2596-600. PubMed ID: 8567889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.
    Coleman AS; Rossmann E; Yang X; Song H; Lamichhane CM; Iyer R; Schwartz I; Pal U
    Clin Vaccine Immunol; 2011 Mar; 18(3):406-13. PubMed ID: 21177911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serological diagnostics of Lyme borreliosis: comparison of assays in twelve clinical laboratories in Northern Europe.
    Lager M; Dessau RB; Wilhelmsson P; Nyman D; Jensen GF; Matussek A; Lindgren PE; Henningsson AJ; ; Baqir H; Serrander L; Johansson M; Tjernberg I; Skarstein I; Ulvestad E; Grude N; Pedersen AB; Bredberg A; Veflingstad R; Wass L; Aleke J; Nordberg M; Nyberg C; Perander L; Bojesson C; Sjöberg E; Lorentzen ÅR; Eikeland R; Noraas S; Henriksson GA; Petrányi G
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1933-1945. PubMed ID: 31399914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of four commercially available ELISA assays for the serologic diagnosis of Lyme disease.
    Christenson VD; White DH
    J Clin Lab Anal; 1991; 5(5):340-3. PubMed ID: 1941354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study.
    Baarsma ME; van de Schoor FR; Gauw SA; Vrijmoeth HD; Ursinus J; Goudriaan N; Popa CD; Ter Hofstede HJ; Leeflang MM; Kremer K; van den Wijngaard CC; Kullberg BJ; Joosten LA; Hovius JW
    Lancet Infect Dis; 2022 Sep; 22(9):1388-1396. PubMed ID: 35714662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
    Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
    Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area.
    Nyman D; Willén L; Jansson C; Carlsson SA; Granlund H; Wahlberg P
    Clin Microbiol Infect; 2006 May; 12(5):496-7. PubMed ID: 16643532
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.
    Hauser U; Krahl H; Peters H; Fingerle V; Wilske B
    J Clin Microbiol; 1998 Feb; 36(2):427-36. PubMed ID: 9466753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic probability classification in suspected borreliosis by a novel
    Nyman D; Nordberg M; Nyberg C; Olausson S; Carlströmer Berthen N; Carlsson SA
    Front Cell Infect Microbiol; 2023; 13():1108115. PubMed ID: 37753485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serological Diagnostics of Lyme Borreliosis: Comparison of Universal and Borrelia Species-Specific Tests Based on Whole-Cell and Recombinant Antigens.
    Kodym P; Kurzová Z; Berenová D; Pícha D; Smíšková D; Moravcová L; Malý M
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30185509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.